Background: The measurement of health state utility values (HSUVs) for a representative
sample of Australian people with multiple sclerosis (MS) has not previously been performed …

abstract Objectives To estimate health state utility values (HSUVs) for multiple sclerosis (MS)
by key demographic and clinical characteristics. Methods Data from a UK prospective …

Background Health-related quality of life (HRQoL) has not been assessed in Australians
with multiple sclerosis (MS) using a preferentially sensitive multi-attribute utility instrument …

Background: Multiple sclerosis (MS) is a debilitating disease, accompanied by neurological
symptoms of varying severity. Utilities are a key summary index measure used in assessing …

Objectives: Because published utility estimates in multiple sclerosis (MS) are concentrated
in people with moderate to severe disease severity and focus on specific types of MS, we …

Purpose The three most widely used utility measures are the Health Utilities Index Mark 2
and 3 (HUI2 and HUI3), the EuroQol-5D (EQ-5D) and the Short-Form-6D (SF-6D). In line …

This cost-of-illness analysis for the United Kingdom is part of a Europe-wide study on the
costs of multiple sclerosis (MS). The objective was to analyze the costs and quality of life …

The study objective was to analyse the costs and quality of life (QOL) of multiple sclerosis
(MS) related to disease severity in Sweden as part of a study in nine European countries …

Background A major debate in the quality-adjusted life-year (QALY) literature concerns
whose preferences should be used to estimate health state values (HSVs) and to calculate …

Background Multiple sclerosis (MS) is a chronic disease associated with several impacts;
especially regarding patients' health-related quality of life (HRQL). EuroQol 5 Dimensions …